Metraipolis › archive › dc_e7dbccaa9994
Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia — Europe PMC PMID:42220484
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42220484
- DOI
- 10.3389/fimmu.2026.1809508
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T09:04:03.572Z
- SHA-256 of the archived text
44eb3dbbb7a8b71dec9ffa06612613850dce592da7d1047836f00509de4614de- Stable URL of this page
https://metraipolis.com/documento/dc_e7dbccaa9994
How to cite
Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia — Europe PMC PMID:42220484 — Europe PMC (en), https://europepmc.org/article/MED/42220484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7dbccaa9994 (Metraipolis archive dc_e7dbccaa9994, sha256 44eb3dbbb7a8b71dec9ffa06612613850dce592da7d1047836f00509de4614de)
BibTeX
@misc{dce7dbccaa9994,
title = {Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia — Europe PMC PMID:42220484},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42220484},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7dbccaa9994; sha256 44eb3dbbb7a8b71dec9ffa06612613850dce592da7d1047836f00509de4614de},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220484. Agents can read the archived copy with the MCP tool read_document.